Select Recent News

MORE

December 18, 2024

Esperion Strengthens Balance Sheet with Closing or Significant Refinancing Transactions

MORE

October 24, 2024

Humana and Longevity Health Multi-State Agreement Expands Access to Humana Together in Health Special Needs Plans

MORE

September 4, 2024

uMotif Buys ClinOne; Integrates Site Applications Including eConsent into eCOA/ePRO Platform for Clinical Trials, Real-World Studies

MORE

August 12, 2024

Crown Laboratories and Revance Announce Entry Into Merger Agreement

MORE

December 27, 2023

Calliditas Refinances Existing Term Loan with Euro 92 Million Senior Secured Facility with Athyrium Capital

MORE

August 14, 2023

U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY® for the Treatment of Cervical Dystonia

MORE

June 26, 2023

Syneos Health and uMotif Partner to Deliver Patient-centric eClinical Platform

MORE

May 4, 2023

Humana and Longevity Health Partner to Expand Access to Special Needs Plans for Medicare Beneficiaries

MORE

September 8, 2022

Revance Announces FDA Approval of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection

MORE

September 7, 2022

Basilea Announces CHF 75 Million Senior Secured Loan Agreement with Athyrium

MORE

August 4, 2022

RVL Pharmaceuticals plc Announces Insider and Athyrium-Led Financing

MORE

July 19, 2022

uMotif Expands Leadership Team to Support Growth in US and EU Markets

MORE

May 25, 2022

uMotif Announces $25.5m Investment from Fund Managed by Athyrium Capital Management

MORE

March 21, 2022

Revance Closes on $300 Million Note Purchase Agreement with Athyrium Capital Management

MORE

March 10, 2022

Puma Biotechnology Announces $10 Million Private Placement

MORE

October 7, 2021

Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium up to $100 Million

MORE

July 26, 2021

Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital

MORE

June 30, 2021

Anthem, Inc. Completes Acquisition of MMM Holdings, LLC and Affiliates From InnovaCare Health, L.P.

MORE

June 15, 2021

Water's Edge Dermatology and Riverchase Dermatology Partner with Goodman Dermatology

MORE

June 10, 2021

Progenity Announces $40 Million Private Placement

MORE

June 8, 2021

Deerfield Healthcare Technology Acquisitions Corp. Announces Closing of Business Combination With CareMax

MORE

June 3, 2021

FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa

MORE

June 2, 2021

Progenity Launches Strategic Transformation into Biotech Company, Focusing on Robust R&D Pipeline

MORE

May 12, 2021

BioCryst Receives UK Approval of ORLADEYO™ to Prevent Attacks in Hereditary Angioedema Patients

MORE

May 5, 2021

Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases

MORE

April 30, 2021

BioCryst Receives European Commission Approval of ORLADEYO™ (berotralstat) to Prevent Heart Attacks

MORE

April 28, 2021

Inivata and Agendia Sign Agreement for Commercialization of RaDaR® MRD Liquid Biopsy Assay in Breast Cancer

MORE

March 23, 2021

Amryt Receives Positive Feedback from FDA on Myalept® (metreleptin) Indication in Partial Lipodystrophy

MORE

February 23, 2021

Recro Announces Amendment to Athyrium Credit Facility

MORE

February 2, 2021

Anthem, Inc. to Acquire MMM Holdings, LLC and Affiliates From InnovaCare Health, L.P.

MORE

January 22, 2021

BioCryst Announces Approval of ORLADEYO™ in Japan for the Prophylactic Treatment of Hereditary Angioedema

MORE

January 6, 2021

Walgreens Boots Alliance Accelerates VillageMD Investment and Large-Scale Rollout of Primary Care Clinics

MORE

December 18, 2020

Deerfield Healthcare Technology Acquisitions Corp. Announces Proposed Business Combination to Form CareMax

MORE

December 10, 2020

ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology

MORE

December 8, 2020

Progenity Announces Closing of Public Offering of Common Stock

MORE

December 8, 2020

Progenity Announces Closing of Convertible Senior Notes Offering

MORE

December 8, 2020

Amryt Announces $40m Private Placement with Leading Biotech Investors

MORE

December 7, 2020

BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management

MORE

December 4, 2020

BioCryst Announces FDA Approval of ORLADEYO™ (Berotralstat) for Hereditary Angiodema

MORE

November 20, 2020

Progenity Releases Prospective Clinical Verification Data for its Preecludia™ Test for Triaging Preeclampsia

MORE

November 18, 2020

Agendia and Paige Announce Landmark Strategic Partnership to Revolutionize Treatment Planning in Breast Cancer

MORE

November 11, 2020

Alcresta Therapeutics’ RELiZORB® (Immobilized Lipase) Cartridge Shows Long-Term Effectiveness

MORE

October 29, 2020

Amryt Announces Positive Results from Phase 3 Trial of FILSUVEZ® in Epidermolysis Bullosa

MORE

October 27, 2020

Kala Pharmaceuticals Announces FDA Approval of EYSUVIS™ for the Short-Term Treatment of Dry Eye Disease

MORE

September 30, 2020

Secura Bio Completes Acquisition of Global Rights to Oncology Drug Copiktra®

MORE

July 8, 2020

Walgreens and VillageMD to Open 500 to 700 Full-Service Doctor Offices within Next Five Years in a Major Industry First

MORE

March 9, 2020

Kala Pharmaceuticals Announces Statistically Significant Results in STRIDE 3 Clinical Trial Evaluating EYSUVIS™

MORE

March 4, 2020

Asahi Kasei Completes Acquisition of Veloxis Pharmaceuticals Inc.

MORE

January 10, 2020

Lilly Announces Agreement to Acquire Dermira

MORE

December 31, 2019

HLS Therapeutics Announces Health Canada Approval for Vascepa® to Reduce the Risk of Cardiovascular Events

MORE

September 25, 2019

Amryt Pharma plc Announces Completion of the Acquisition of Aegerion Pharmaceuticals, Inc.

MORE

June 25, 2019

Alcresta Therapeutics Announces Publication of Consensus Statement Supporting Access to RELiZORB®

MORE

March 5, 2019

Secura Bio Announces $145 Million Financing Led By Athyrium Capital Management

MORE

March 4, 2019

Recro Pharma Obtains $40.5 Million of Non-Dilutive Capital Through Expanded Credit Facility

MORE

March 1, 2019

Portola Pharmaceuticals Enters into $125 Million Loan Agreement with HealthCare Royalty Partners and Athyrium Capital Management

MORE

December 04, 2018

Dermira Enters into Credit Facility with Athyrium Capital Management

MORE

November 08, 2018

Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update

MORE

October 02, 2018

Kala Pharmaceuticals Announces Financing from Athyrium Capital Management Totaling $110 Million

MORE

July 25, 2018

Agendia Secures $35 Million Investment from Funds Managed by Athyrium Capital Management

MORE

June 4, 2018

Gryphon Investors Announces Majority Investment in Water's Edge Dermatology

MORE

May 1, 2018

VIVUS Restructures Debt and Gains Access to New Capital

MORE

April 3, 2018

Biom'up and Athyrium Close First Tranche of Bond Financing for €25 Million with Stock Warrants Attached

MORE

February 14, 2018

Veloxis Secures $60M in Debt Financing

MORE

January 4, 2018

VillageMD Announces $80 Million Growth Financing from Athyrium Capital Management

MORE

January 2, 2018

Optinose Announces $100 Million Debt Financing from Athyrium Capital Management

MORE

December 22, 2017

Centinel Spine Completes Acquisition of Prodisc Assets

MORE

November 20, 2017

Recro Pharma Secures $100 Million Credit Facility

MORE

November 7, 2017

Progenity Announces Closing of $125 Million Financing for Prenatal- Women's Health Genetics and IBD Precision Medicine

MORE

February 2, 2017

Comvest Announces Acquisition of Interamerican Medical Center Group

MORE

September 8, 2016

Apollo Endosurgery and Lpath Sign Merger Agreement

MORE

September 6, 2016

Pharmaceutics International, Inc. Received $93 Million in Growth Capital

MORE

August 9, 2016

Medicrea Announces €20 Million Financing to Support Commercial Expansion of Patient-Specific UNiD™ Rods for Spine Surgery

MORE

July 21, 2016

Galenica to Acquire Relypsa to Strengthen its Business Unit, Vifor Pharma

MORE

May 23, 2016

Arbor Pharmaceuticals to Acquire XenoPort

MORE

May 3, 2016

Relypsa Announces $150 Million Debt Financing

MORE

March 3, 2016

Alvogen Announces Acquisition to Expand U.S. Business

MORE

January 4, 2016

Halozyme Enters Into Agreement For $150 Million Non-Dilutive Royalty-Backed Debt Financing

MORE

August 12, 2015

AMAG Pharmaceuticals Announces Pricing of Private Offering of $500 Million of Senior Notes Due 2023

MORE

July 20, 2015

Athyrium Capital Management and Neuberger Berman Close $1.2 Billion Healthcare Fund

MORE

April 29, 2015

Progenity Acquires Carmenta Bioscience for Proprietary Preeclampsia Technology

MORE

April 13, 2015

Cipher Pharmaceuticals Announces U.S. Commercial Entry Through Acquisition of INNOCUTIS

MORE

March 18, 2015

Retrophin to Acquire Rights to Cholbam from Asklepion Pharmaceuticals

MORE

March 5, 2015

Mallinckrodt Pharmaceuticals to Acquire Ikaria, Inc. for $2.3 Billion

MORE

February 27, 2015

Apollo Endosurgery Completes $50 Million Financing

MORE

February 2, 2015

Extension of option to draw additional funds from the Athyrium term loan facility

MORE

January 5, 2015

Valneva Signs an Agreement to Acquire Dukoral® Vaccine

MORE

December, 2014

Zealand Raises USD 50 / DKK 300 Million in a Royalty Bond Financing

MORE

5 December, 2014

Tecomet, Inc. Acquires Symmetry Medical OEM Solutions Business

MORE

19 September, 2014

Horizon Pharma Completes Acquisition of Vidara Therapeutics International

MORE

19 August, 2014

Pernix Therapeutics Closes on Acquisition of Treximet. Raises $220m Senior Notes

MORE

16 July, 2014

Pfizer to Acquire InnoPharma, Inc.

MORE

1 July, 2014

Retrophin Closes $91 Million Financing

MORE

5 March, 2014

Merger of CCBR-SYNARC and BioClinica, Inc.

MORE

February 2014

Madison Dearborn Partners to Acquire Ikaria

MORE

5 February 2014

Pernix Attracts $65 Million Institutional Investment

MORE

20 December 2013

Universal Biosensors Secures up to $25 Million Loan Facility

MORE

17 December 2013

Total Artificial Heart Manufacturer SynCardia Secures $14 Million in Growth Financing

MORE

19 November 2013

Horizon Pharma Announces Pricing of $150 Million of 5.00% Convertible Senior Notes

MORE

13 November 2013

InnoPharma Inc. Completes $20 Million Term Loan Facility

MORE

20 September 2013

Verenium Enters Agreement to be Acquired by BASF

MORE

3 September 2013

bioMerieux to Acquire BioFire Diagnostics for $450 Million Plus Net Financial Debt

MORE

9 July 2013

Tria Beauty, Inc. Announces the Closing of $45.5 Million in New Equity Financing and a New Structured Debt Facility

MORE

20 May 2013

Neuberger Berman and Athyrium Capital Management Close $507 Million Healthcare Credit Fund

MORE

16 May 2013

VIVUS Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes

MORE

22 April 2013

BioFire Diagnostics, Inc. Expands Financing Commitment from Athyrium Opportunities Fund to $45 Million

MORE

20 March 2013

Total Artificial Heart Manufacturer SynCardia Secures $19M Financing

MORE

28 January 2013

Stemline Therapeutics, Inc. Announces Pricing of Initial Public Offering of 3,317,644 Shares of Common Stock

MORE

7 January 2013

MedPro Agrees to Sell Patents on Three Blood Collection and Infusion Products to Greiner Bio-One

MORE

4 January 2013

Ironwood Completes $175 Million Debt Offering

MORE

10 December 2012

Verenium Announces $22.5 Million, Five-Year Secured Financing

MORE

18 September 2012

BioFire Diagnostics, Inc. Secures $25 Million Financing from Athyrium Opportunities Fund

MORE

6 October 2010

MedPro Safety Products Completes Second Royalty Monetization Transaction

MORE

1 September 2010

MedPro Safety Products Completes Royalty Monetization Transaction